Pacira BioSciences (PCRX) Tax Rate Growth (3y) (2016 - 2026)
Pacira BioSciences (PCRX) Tax Rate Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Pacira BioSciences | 1.07 Bn | 870.64 Mn | 140.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,545.00 |
| Dec 31, 2025 | -23,078.00 |
| Sep 30, 2025 | -9,053.00 |
| Jun 30, 2025 | -16,121.00 |
| Mar 31, 2025 | 3,834.00 |
| Dec 31, 2024 | 1,993.00 |
| Sep 30, 2024 | -3,044.00 |
| Jun 30, 2024 | 2,277.00 |
| Mar 31, 2024 | 1,531.00 |
| Dec 31, 2023 | 4,069.00 |
| Sep 30, 2023 | 205,035.00 |
| Jun 30, 2023 | 3,137.00 |
| Mar 31, 2023 | 2,153.00 |
| Dec 31, 2022 | 8,272.00 |
| Sep 30, 2022 | 13,865.00 |
| Jun 30, 2022 | 15,192.00 |
| Mar 31, 2022 | 1,644.00 |
| Dec 31, 2021 | 1,677.00 |
| Sep 30, 2021 | 1,829.00 |
| Jun 30, 2021 | 2,426.00 |